By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > Does Ingrezza cause weight gain?

Does Ingrezza cause weight gain?

Answers by TheMediTary.Com - Last updated: 13-Jul-2023

Weight gain has been reported in a 6-week clinical study with Ingrezza, but it is not a common side effect. In this study with 151 patients taking either the 40 mg/day or 80 mg/day dose, 3 patients had weight gain (2%) compared to zero patients (0%) in the placebo (inactive treatment) group.

  • Out of 72 patients who received the 40 mg/day dose, one patient (1.4%) had a weight increase.
  • Out of 79 patients who received the 80 mg/day dose, two patients (2.5%) had a weight gain.
  • Your doctor may prescribe Ingrezza with other medicines, such as antipsychotic medications, that can lead to weight gain. Speak with your doctor if you are concerned about weight gain with your treatment regimen.

Ingrezza (valbenazine) is approved by the FDA to treat adults with tardive dyskinesia, which is a disorder that causes movements that cannot be controlled in the face, tongue, or other body parts. It works by blocking certain chemicals in your body that may be involved with involuntary muscle movement.

In general, Ingrezza is well-tolerated. In studies, a total of 3% of Ingrezza-treated patients and 2% of placebo-treated patients stopped treatment due to side effects.

The most common side effect (≥5% and twice the rate of placebo) reported with Ingrezza is somnolence (sleepiness) in 10.9% of patients, compared to 4.2% of patients taking a placebo. Other possible side effects are abnormal heart rhythms, Parkinson-like symptoms (movement disorders), dry mouth, headache, constipation, restlessness, and blurred vision.

Do not drive, operate machinery, or do any hazardous activity that requires mental alertness until you know how Ingrezza affects you.

Ingrezza is taken as an oral capsule once a day, with or without food. It is available as a 40 mg, 60 mg and 80 mg capsules. If you have liver disease, you may need a lower dose. Your doctor will determine your specific dose. Do not stop taking your medicine without speaking with your healthcare provider first.

Neurocrine Biosciences is the manufacturer and it is available through a special pharmacy network in the U.S.

This is not all the information you need to know about Ingrezza (valbenazine) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Ingrezza information here, and discuss this information and any questions you have with your doctor or other health care provider.

Share this Article

Featured questions

  • Austedo vs Ingrezza: How do they compare?
  • How long does it take for Ingrezza to work?
  • How effective is Ingrezza?
  • Ingrezza mechanism of action: How does it work?
  • What condition is Ingrezza used to treat?
  • Can Ingrezza capsules be opened?
  • How much does Ingrezza cost?
  • Which pharmacies can dispense Ingrezza?
  • Can these drugs be used in Thalassemia patients?
  • How does Lupron (leuprolide) work for prostate cancer?
  • What is the consideration to use nifidepine over amlodipine?
  • Hypertrophic cardiomyopathy/mechanical heart valve?
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by